Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000130
HKD
2.02
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 17.43%

 
2

Company has very low debt and has enough cash to service the debt requirements

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 18.15%

 
4

Flat results in Jun 25

 
5

With ROE of 8.73%, it has a Attractive valuation with a 0.20 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 376 Million ()

stock-summary
P/E

2.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

36.96%

stock-summary
Debt Equity

-0.39

stock-summary
Return on Equity

8.73%

stock-summary
Price to Book

0.20

Revenue and Profits:
Net Sales:
205 Million
(Quarterly Results - Dec 2016)
Net Profit:
62 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.91%
0%
-6.91%
6 Months
-6.05%
0%
-6.05%
1 Year
20.24%
0%
20.24%
2 Years
14.77%
0%
14.77%
3 Years
85.32%
0%
85.32%
4 Years
75.65%
0%
75.65%
5 Years
74.14%
0%
74.14%

Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.15%
EBIT Growth (5y)
21.33%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.43
Tax Ratio
14.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.76%
ROE (avg)
17.43%

Valuation key factors

Factor
Value
P/E Ratio
2
Industry P/E
Price to Book Value
0.20
EV to EBIT
-2.08
EV to EBITDA
-1.96
EV to Capital Employed
-0.32
EV to Sales
-0.48
PEG Ratio
0.16
Dividend Yield
37.13%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
8.73%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2016 is 20.65% vs -39.82% in Dec 2015",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2016 is 37.11% vs -38.02% in Dec 2015",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'16",
        "Dec'15",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "205.10",
          "val2": "170.00",
          "chgp": "20.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "65.30",
          "val2": "47.30",
          "chgp": "38.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "61.70",
          "val2": "45.00",
          "chgp": "37.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "297.10%",
          "val2": "265.40%",
          "chgp": "3.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 2.74% vs -4.99% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 21.98% vs -27.23% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "955.40",
          "val2": "929.90",
          "chgp": "2.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "205.70",
          "val2": "179.70",
          "chgp": "14.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.20",
          "val2": "0.60",
          "chgp": "266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.30",
          "val2": "-0.40",
          "chgp": "1,675.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "199.80",
          "val2": "163.80",
          "chgp": "21.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "184.50%",
          "val2": "160.50%",
          "chgp": "2.40%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'16 - YoYstock-summary

Dec'16
Dec'15
Change(%)
Net Sales
205.10
170.00
20.65%
Operating Profit (PBDIT) excl Other Income
65.30
47.30
38.05%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
61.70
45.00
37.11%
Operating Profit Margin (Excl OI)
297.10%
265.40%
3.17%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2016 is 20.65% vs -39.82% in Dec 2015

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2016 is 37.11% vs -38.02% in Dec 2015

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
955.40
929.90
2.74%
Operating Profit (PBDIT) excl Other Income
205.70
179.70
14.47%
Interest
2.20
0.60
266.67%
Exceptional Items
6.30
-0.40
1,675.00%
Consolidate Net Profit
199.80
163.80
21.98%
Operating Profit Margin (Excl OI)
184.50%
160.50%
2.40%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 2.74% vs -4.99% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 21.98% vs -27.23% in Dec 2023

stock-summaryCompany CV
About Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. stock-summary
stock-summary
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available